Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02624596
PHASE2

Understanding How Ketamine Brings About Rapid Improvement in OCD

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

Official title: NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2016-06

Completion Date

2026-06

Last Updated

2025-05-31

Healthy Volunteers

Yes

Interventions

DRUG

Ketamine

OCD patients in this arm will receive 0.5mg/kg of ketamine - one single infusion

DRUG

Midazolam

OCD patients in this arm will receive 0.045mg/kg of midazolam - one single infusion

Locations (1)

Stanford University

Stanford, California, United States